Deep Dives, AI, Drug Development, Drug Discovery.
its AI models — one to predict if breast cancer patients will relapse after treatment, and another that can determine whether cases of colorectal cancer contain microsatellite instability — have now received CE mark approval, allowing them to be used on cancer patients across Europe. It is also